HIMS | Hims & hers health inc - Stock Value & PE Ratio Analysis

3

24

15

Excellent Growth

AI analysis rates HIMS with the highest value score of 5.
It is mainly due to stable revenue growth, along with adequate operating cash flow.
Over the past 3 months, HIMS has maintained a consecutive value rating of 5.0, higher than the rating of 2.6 over the past 3 years, indicating noticeable improvement in enterprise value.
Compared to all stocks in the Health Care sector, HIMS has a higher value rating.

HIMS Value Reference Factors

The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.

Update to 2025/02/28 (Weekly Update)

HIMS Financial Forecast

Unit : USD

Update to 2025/5/4 (Quarterly Update)

HIMS Earnings Table

Unit : USD

QTR	Non-GAAP EPS	EPS YoY	EPS Surprise %	Sales	Sales YoY	Sales Surprise %	NPM
Current	0.11	1,000%	22.2%	481.14M	95.1%	-2.7%	18.8%
2024Q2	0.06	250%	0%	401.56M	77.1%	-14.5%	4.2%
2024Q1	0.06	300%	40.4%	315.65M	51.8%	5.2%	4%
2023Q4	0.05	200%	316.7%	278.17M	45.8%	2.9%	0.5%
2023Q3	0.01	120%	150%	246.62M	47.5%	0.3%	-3.3%

Update to 2025/5/8 (Quarterly Update)

HIMS Historical Value Score

You can use historical scores of 3 or above to observe potential performance and make investment decisions.

HIMS Value Strategy Backtest

The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.

Entry

Exit

The Backtest Result of HIMS from 2019/11 till Now

169.57%
Cumulative Return: 20.37%
Annual Return: 45.15%
Volatility: 0.45
Sharpe Ratio

Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from November, 2019 to May, 2025. (Total Trades: 1)